India Glycols Ltd. Share Price

Understanding Technical Analysis India Glycols

The stock

is showing a bullish structure on the daily chart. After finding strong support around ₹800–850 the stock has formed a series of higher highs and higher lows. The recent correction from ₹1200 towards ₹1050 was followed by a strong recovery and the stock is again trading near ₹1145. This indicates that buyers are still active. Support & Resistance: Immediate support is around ₹1100–1080 followed by stronger support near ₹1040–1020. On the upside ₹1180–1200 is the key resistance zone. A strong daily close above ₹1200 with good volume can open the way towards ₹1250–1300. Short-Term Outlook: The setup remains bullish above ₹1080. Fresh buyers can wait for a breakout above ₹1,200 with volume, or look for a pullback towards ₹1100–1080 with a bullish reversal. Existing holders can continue holding with a trailing stop-loss around ₹1040. A decisive close below ₹1040 would weaken the bullish structure and could lead to a deeper correction towards ₹1000–980.

See More

India Glycols has reported strong Q1 FY27 results

India Glycols has reported strong Q1 FY27 results with revenue up 9% to ₹1,130 crore and EBITDA up 13% to ₹170 crore. The National Company Law Tribunal (NCLT) has sanctioned its demerger plan, paving the way for three separate listed entities. 📊 Key Financial Highlights (Q1 FY27) Revenue: ₹1,130 crore (↑ 9% YoY) EBITDA: ₹170 crore (↑ 13% YoY) PAT (Profit After Tax): ↑ 32% YoY Finance Costs: Reduced to ₹25 crore (from ₹45 crore last year) due to debt reduction efforts 🔑 Strategic Updates Demerger Approved: NCLT sanctioned restructuring into three entities: IGL Spirits Limited – Potable spirits & bio-fuel Ennature Bio Pharma – Nutraceuticals, APIs, biopolymers India Glycols Limited – Bio-based chemicals, glycols, performance chemicals, gases Debt-Free Target: Company aims to be debt-free by FY28. Segment Growth: Spirits: Revenue ₹361 crore (↑ 5.3%), IMFL volumes surged 55% YoY. Bio-Fuel: Revenue ₹323 crore (↑ 7%), EBIT margin 8.4%. Chemicals: Revenue ₹362 crore (↑ 20.6%), performance chemicals grew 40%. ⚠️ Risks & Challenges Raw Material Volatility: Crude oil price fluctuations impacting margins. Freight Costs: Significant spikes affecting exports. Geopolitical Disruptions: Shipments to Middle East & US facing delays. Execution Risk: Smooth transition during demerger remains critical. 📌 Investor Takeaways Positive Outlook: Strong revenue & EBITDA growth, reduced debt, and demerger expected to unlock shareholder value. Valuation Potential: Focused entities may attract differentiated valuations. Watchpoints: Monitor raw material costs, freight rates, and execution of restructuring plan.

See More

India Glycols’ Big Split: Unlocking Value or Just Repackaging It?

India Glycols is moving through a major restructuring that may finally unlock value hidden inside the company. The NCLT has sanctioned its three-way split, and that is important because the market has long valued the business as one mixed basket instead of pricing each division separately. The company currently runs four businesses: Bio-based Specialities and Performance Chemicals, Potable Spirits, Bio-Fuel, and Ennature Bio. Under the approved plan, Potable Spirits and Bio-Fuel will be housed in IGL Spirits Limited, while the bio-pharma and bio-polymer business will go into Ennature Bio Pharma Limited. The remaining specialty chemicals business will stay with India Glycols. Shareholders will receive 1 share of IGL Spirits for every 1 share held, and 1 share of Ennature Bio Pharma for every 3 shares held. The logic is clear. Spirits is a higher-margin business, and separating it from chemicals can help investors value it more fairly. Today, the market values India Glycols as a blended entity at about ₹6,600 crore, around 22x earnings and 13x EV/EBITDA. That suggests the market may not yet be giving full credit to the better parts of the business. Recent numbers also look supportive. In Q4 FY26, the company reported revenue of ₹2,360 crore, EBITDA of ₹167.1 crore, and net profit of ₹86.9 crore, with profit up 35.7% year on year. These figures show that the underlying businesses are performing well enough for a cleaner structure to matter. For shareholders, this can be beneficial if the new companies get better valuation multiples and stronger analyst attention. The risk is that the value unlock may take time, and the market could apply discounts until the listing process is complete. Still, if execution is smooth, the split looks more value-creating than harmful.

See More

🟢 Range Breakout with Momentum Expansion — India Glycols Ready for Next Leg Up!

📊 Technical + Structural Analysis India Glycols is showing a clean breakout from a prolonged accumulation range, backed by strong price action and structural shift: 🌊 Elliott Wave Perspective The stock appears to have completed a corrective ABC structure within the broad range (₹820–₹1000). The recent breakout above ₹1000 marks the beginning of a fresh impulsive Wave 1 / Wave 3. If momentum sustains, this could evolve into a strong trending phase, with upside targets toward ₹1120–₹1150. 📉 MACD Insight Momentum has clearly shifted bullish after a prolonged consolidation. Likely bullish crossover with expansion in histogram, indicating trend initiation rather than exhaustion. No visible divergence — supports continuation move. 📍 AVWAP Confluence The ₹1000–₹1010 zone acted as a multi-month AVWAP resistance. Clean breakout and close above this level = change of polarity (resistance → support). Any pullback toward this zone can act as a high-probability demand area. 🧠 Price Action Context Strong bullish breakout candle = institutional participation Range contraction → expansion = volatility breakout setup Follow-through buying seen = confirmation strength 📈 Fundamental Snapshot Strong presence in specialty chemicals and bio-based products Beneficiary of global shift toward sustainable chemicals Improving operating margins and profitability Healthy balance sheet with stable growth outlook ⚖️ Conclusion Short-term: Bullish breakout continuation Medium-term: Trend reversal confirmed above ₹1000 Upside potential: ₹1120–₹1150 Key support: ₹1000–₹1010 zone 👉 This is a momentum breakout stock — ideal for traders looking to ride trend expansion with disciplined risk management.

See More

India Glycols Shares in Focus After Dividend Announcement

Shares of India Glycols remained in focus on the NSE after the company announced an interim dividend of ₹7.5 per equity share for the current financial year. The record date has been fixed to determine eligible shareholders, and the payout is expected within a stipulated period. The announcement has attracted investor attention as dividend-paying stocks often see short-term buying interest. Market participants are closely watching the stock as steady earnings and shareholder returns continue to support sentiment around the company Disclaimer: Investments in securities are subject to market risk. This is for educational purposes only. Investors must verify information before investing and consider their financial position & risk profile.

See More